Products

Article

A round-up of the latest ophthalmic products

Multifocal IOL

This lens features additive paraxial asphericity (APA) to enhance far and near focus zones for better depth of focus and a balanced vision at all distances, offer good visual performance in intermediate vision field through adapted zone focusing and interpret neuronal images easily as a result of intelligent focal modulation for all light conditions.

Further information can be found at http://www.oculentis.de/lentis-mplus-x.html

Tear lubricants

The company has reported this new proprietary range will start with two products: a multidose preservative-free lubricating ointment for night-time relief of dry eye sensations; and a unit-dose preservative-free lubricant that alleviates and soothes dry eye sensations.

Included within this range will be medical devices developed by Medicom Healthcare, a UK-based pharmaceutical company specializing in ophthalmics, through an exclusive supply and distribution agreement.

For more detailed information on this new range visit http://www.nicox.com/

Digital imaging system

This software is capable of acquiring, displaying, enhancing, analysing and saving digital images obtained with a variety of Topcon photographic devices, such as mydriatic and non-mydriatic retinal cameras and photo slit lamps.

Additionally, the company reports that it features a robust SQL expanded database and has numerous image management functions that facilitate image acquisition, enhancement, measurement and comparison. With its full DICOM compatibility, this system can be used in a variety of environments, from private offices to large medical institutions.

Furthermore, it is stated that the IMAGEnet 5 easily integrates with the company's Synergy Ophthalmic Data Management System.

More information on this system can be found on the company's website http://www.topconmedical.com/

Glaucoma module edition

The software is reported to offer comprehensive analyses for optic nerve head (ONH), retinal nerve fibre layer (RNFL) and posterior pole asymmetry. Including a new Anatomic Positioning System (APS) for the SPECTRALIS, the company states that all OCT-scans are accurately placed relative to the position of the fovea and Bruch's Membrane opening (BMO), which are used as anatomical landmarks of the eye.

Additionally, the company reported that the new optic nerve head assessment is based on the research performed by Professor Chauhan's group and Professor Burgoyne's group. Using the SPECTRALIS SD-OCT, the researchers revealed the importance of making an anatomically and geometrically accurate neuroretinal rim measurement using BMO rather than the clinical disc margin.

Therefore, the new software measures from the BMO to the nearest point at the internal limiting membrane (ILM), quantifying the minimum cross section of the nerve fibres exiting the eye. This means that the BMO-based minimum rim width (BMO-MRW) can be assessed and regionalized relative to the axis between BMO and the fovea for accurate analyses.

For more information please visit http://www.HeidelbergEngineering.com/

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.